Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2010

01-02-2010 | Glaucoma

Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma

Authors: Kenya Yuki, Dogru Murat, Itaru Kimura, Yuichiro Ohtake, Kazuo Tsubota

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 2/2010

Login to get access

Abstract

Background

Vitamin A, B9, C, E, and uric acid are well-known antioxidants and may prevent age-related eye disorders. The aim of the present study was to investigate the levels of antioxidant vitamins, A, B9, C, E, and antioxidative substance, uric acid in the serum of Japanese patients with normal-tension glaucoma and compare the results with normal controls.

Methods

All subjects with suspicion of primary open-angle glaucoma who came to the glaucoma subspeciality clinic of Keio University Hospital were enrolled in this study. Sixty patients (28 males, 32 females; mean age ± standard deviation: 59.9 ± 9.8 years) with newly diagnosed primary open-angle glaucoma patients were consecutively enrolled in this study. After the diagnosis of primary open-angle glaucoma, the patients underwent 24-h IOP measurements. Forty-seven newly diagnosed consecutive normal-tension glaucoma patients (18 males, 29 females; mean age ± standard deviation: 59.5 ± 10.2 years) were enrolled in this study. The control subjects were recruited from subjects who came to the clinic for annual refractive check-up. The 44 consecutive control subjects of the current study, (16 males, 28 females; 62.7 ± 14.8 years) did not have any ocular diseases. The serum levels of vitamins A, B9, C, E, and uric acid were measured. The values were compared between the normal-tension glaucoma and control groups by the Mann-Whitney U test.

Results

Serum levels of vitamin C were significantly lower in normal-tension glaucoma patients than in normal healthy controls (P = 0.04; normal-tension glaucoma; 4.6 ± 4.0 μg/ml control; 6.3 ± 3.9 μg/ml). Uric acid level was significantly higher in normal-tension glaucoma patients than in controls (P = 0.01; normal-tension glaucoma; 5.8 ± 1.5 mg/dl control; 4.9 ± 1.4 mg/dl). No statistically significant difference was seen in vitamin A (P = 0.41; normal-tension glaucoma; 82.1 ± 26.7 μg/dl control; 77.1 ± 30.1 μg/dl), B9 (P = 0.37; normal-tension glaucoma; 8.7 ± 4.3 ng/ml control; 8.0 ± 3.1 ng/ml)and E (P = 0.83; normal-tension glaucoma; 1.5 ± 0.6 control; 1.5 ± 0.6) levels between normal-tension glaucoma and control groups.

Conclusion

Normal-tension glaucoma patients had lower serum levels of vitamin C and increased levels of uric acid. These observations may pave the way for possible alternative treatment for normal-tension glaucoma.
Literature
1.
go back to reference Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, HK M, Shimizu H, Tomita G, Inoue Y, Kitazawa Y (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111:1641–1648PubMed Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, HK M, Shimizu H, Tomita G, Inoue Y, Kitazawa Y (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111:1641–1648PubMed
2.
go back to reference Shields MB (2008) Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 19:85–88CrossRefPubMed Shields MB (2008) Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 19:85–88CrossRefPubMed
3.
go back to reference Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490–513CrossRefPubMed Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490–513CrossRefPubMed
4.
go back to reference Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A (2005) Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 123:458–463CrossRefPubMed Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A (2005) Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 123:458–463CrossRefPubMed
5.
go back to reference Feilchenfeld Z, Yucel YH, Gupta N (2008) Oxidative injury to blood vessels and glia of the pre-laminar optic nerve head in human glaucoma. Exp Eye Res 87:409–414CrossRefPubMed Feilchenfeld Z, Yucel YH, Gupta N (2008) Oxidative injury to blood vessels and glia of the pre-laminar optic nerve head in human glaucoma. Exp Eye Res 87:409–414CrossRefPubMed
6.
go back to reference Sacca SC, Izzotti A, Rossi P, Traverso C (2007) Glaucomatous outflow pathway and oxidative stress. Exp Eye Res 84:389–399CrossRefPubMed Sacca SC, Izzotti A, Rossi P, Traverso C (2007) Glaucomatous outflow pathway and oxidative stress. Exp Eye Res 84:389–399CrossRefPubMed
7.
go back to reference Mozaffarieh M, Grieshaber MC, Flammer J (2008) Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis 14:224–233PubMed Mozaffarieh M, Grieshaber MC, Flammer J (2008) Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis 14:224–233PubMed
8.
go back to reference Kumar DM, Agarwal N (2007) Oxidative stress in glaucoma: a burden of evidence. J Glaucoma 16:334–343CrossRefPubMed Kumar DM, Agarwal N (2007) Oxidative stress in glaucoma: a burden of evidence. J Glaucoma 16:334–343CrossRefPubMed
9.
go back to reference Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF (2004) Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 137:62–69CrossRefPubMed Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF (2004) Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 137:62–69CrossRefPubMed
10.
go back to reference Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL (2005) Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46:877–883CrossRefPubMed Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL (2005) Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46:877–883CrossRefPubMed
11.
go back to reference Inokuchi Y, Imai S, Nakajima Y, Shimazawa M, Aihara M, Araie M, Hara H (2009) Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J Pharmacol Exp Ther 329:687–698CrossRefPubMed Inokuchi Y, Imai S, Nakajima Y, Shimazawa M, Aihara M, Araie M, Hara H (2009) Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J Pharmacol Exp Ther 329:687–698CrossRefPubMed
12.
go back to reference Shimazawa M, Nakajima Y, Mashima Y, Hara H (2009) Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res 1251:269–275CrossRefPubMed Shimazawa M, Nakajima Y, Mashima Y, Hara H (2009) Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res 1251:269–275CrossRefPubMed
13.
go back to reference Munemasa Y, Ahn JH, Kwong JM, Caprioli J, Piri N (2009) Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther 16:17–25CrossRefPubMed Munemasa Y, Ahn JH, Kwong JM, Caprioli J, Piri N (2009) Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther 16:17–25CrossRefPubMed
14.
go back to reference Nakajima Y, Inokuchi Y, Nishi M, Shimazawa M, Otsubo K, Hara H (2008) Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 1226:226–233CrossRefPubMed Nakajima Y, Inokuchi Y, Nishi M, Shimazawa M, Otsubo K, Hara H (2008) Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 1226:226–233CrossRefPubMed
15.
go back to reference Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, Tanaka K (2007) The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 117:1763–1770CrossRefPubMed Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, Tanaka K (2007) The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 117:1763–1770CrossRefPubMed
16.
17.
go back to reference Coleman H, Chew E (2007) Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18:220–223CrossRefPubMed Coleman H, Chew E (2007) Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18:220–223CrossRefPubMed
18.
go back to reference Milton RC, Sperduto RD, Clemons TE, Ferris FL 3rd (2006) Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21. Ophthalmology 113:1264–1270CrossRefPubMed Milton RC, Sperduto RD, Clemons TE, Ferris FL 3rd (2006) Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21. Ophthalmology 113:1264–1270CrossRefPubMed
19.
go back to reference Evans J (2008) Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye 22:751–760CrossRefPubMed Evans J (2008) Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye 22:751–760CrossRefPubMed
20.
go back to reference Suzuki S, Suzuki Y, Iwase A, Araie M (2005) Corneal thickness in an ophthalmologically normal Japanese population. Ophthalmology 112:1327–1336CrossRefPubMed Suzuki S, Suzuki Y, Iwase A, Araie M (2005) Corneal thickness in an ophthalmologically normal Japanese population. Ophthalmology 112:1327–1336CrossRefPubMed
21.
go back to reference Evans JR, Henshaw K (2008) Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev CD000253 Evans JR, Henshaw K (2008) Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev CD000253
22.
go back to reference Yokoyama T, Date C, Kokubo Y, Yoshiike N, Matsumura Y, Tanaka H (2000) Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community. The Shibata Study. Stroke 31:2287–2294PubMed Yokoyama T, Date C, Kokubo Y, Yoshiike N, Matsumura Y, Tanaka H (2000) Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community. The Shibata Study. Stroke 31:2287–2294PubMed
23.
go back to reference Varma SD (1991) Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 53:335S–345SPubMed Varma SD (1991) Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 53:335S–345SPubMed
24.
go back to reference Yoshida M, Takashima Y, Inoue M, Iwasaki M, Otani T, Sasaki S, Tsugane S (2007) Prospective study showing that dietary vitamin C reduced the risk of age-related cataracts in a middle-aged Japanese population. Eur J Nutr 46:118–124CrossRefPubMed Yoshida M, Takashima Y, Inoue M, Iwasaki M, Otani T, Sasaki S, Tsugane S (2007) Prospective study showing that dietary vitamin C reduced the risk of age-related cataracts in a middle-aged Japanese population. Eur J Nutr 46:118–124CrossRefPubMed
25.
go back to reference Becker B (1957) Chemical composition of human aqueous humor; effects of acetazoleamide. AMA Arch Ophthalmol 57:793–800PubMed Becker B (1957) Chemical composition of human aqueous humor; effects of acetazoleamide. AMA Arch Ophthalmol 57:793–800PubMed
26.
go back to reference KInsey V (1947) Transfer of ascorbic acid and related compounds across the blood-aqueous barrier. Am J Ophthalmol 30:1262–1266 KInsey V (1947) Transfer of ascorbic acid and related compounds across the blood-aqueous barrier. Am J Ophthalmol 30:1262–1266
27.
go back to reference Purcell EF, Lerner LH, Kinsey VE (1954) Ascorbic acid in aqueous humor and serum of patients with and without cataract 51:1–6 Purcell EF, Lerner LH, Kinsey VE (1954) Ascorbic acid in aqueous humor and serum of patients with and without cataract 51:1–6
28.
go back to reference Virno M, Bucci MG, Pecori-Giraldi J, Cantore G (1966) Intravenous glycerol-vitamin C (sodium salt) as osmotic agents to reduce intraocular pressure. Am J Ophthalmol 62:824–833PubMed Virno M, Bucci MG, Pecori-Giraldi J, Cantore G (1966) Intravenous glycerol-vitamin C (sodium salt) as osmotic agents to reduce intraocular pressure. Am J Ophthalmol 62:824–833PubMed
29.
go back to reference Fishbein SL, Goodstein S (1972) The pressure lowering effect of ascorbic acid. Ann Ophthalmol 4:487–491PubMed Fishbein SL, Goodstein S (1972) The pressure lowering effect of ascorbic acid. Ann Ophthalmol 4:487–491PubMed
30.
go back to reference Linner E (1969) The pressure lowering effect of ascorbic acid in ocular hypertension. Acta Ophthalmol (Copenh) 47:685–689CrossRef Linner E (1969) The pressure lowering effect of ascorbic acid in ocular hypertension. Acta Ophthalmol (Copenh) 47:685–689CrossRef
31.
go back to reference Hosoya K, Minamizono A, Katayama K, Terasaki T, Tomi M (2004) Vitamin C transport in oxidized form across the rat blood-retinal barrier. Invest Ophthalmol Vis Sci 45:1232–1239CrossRefPubMed Hosoya K, Minamizono A, Katayama K, Terasaki T, Tomi M (2004) Vitamin C transport in oxidized form across the rat blood-retinal barrier. Invest Ophthalmol Vis Sci 45:1232–1239CrossRefPubMed
32.
go back to reference Hosoya K, Nakamura G, Akanuma S, Tomi M, Tachikawa M (2008) Dehydroascorbic acid uptake and intracellular ascorbic acid accumulation in cultured Muller glial cells (TR-MUL). Neurochem Int 52:1351–1357CrossRefPubMed Hosoya K, Nakamura G, Akanuma S, Tomi M, Tachikawa M (2008) Dehydroascorbic acid uptake and intracellular ascorbic acid accumulation in cultured Muller glial cells (TR-MUL). Neurochem Int 52:1351–1357CrossRefPubMed
33.
go back to reference Portugal CC, Miya VS, Calaza Kda C, Santos RA, Paes-de-Carvalho R (2009) Glutamate receptors modulate sodium-dependent and calcium-independent vitamin C bidirectional transport in cultured avian retinal cells. J Neurochem 108:507–520CrossRefPubMed Portugal CC, Miya VS, Calaza Kda C, Santos RA, Paes-de-Carvalho R (2009) Glutamate receptors modulate sodium-dependent and calcium-independent vitamin C bidirectional transport in cultured avian retinal cells. J Neurochem 108:507–520CrossRefPubMed
34.
go back to reference Dong XX, Wang Y, Qin ZH (2009) Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 30:379–387CrossRefPubMed Dong XX, Wang Y, Qin ZH (2009) Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 30:379–387CrossRefPubMed
35.
go back to reference Munemasa Y, Kim SH, Ahn JH, Kwong JM, Caprioli J, Piri N (2008) Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci 49:3535–3543CrossRefPubMed Munemasa Y, Kim SH, Ahn JH, Kwong JM, Caprioli J, Piri N (2008) Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci 49:3535–3543CrossRefPubMed
36.
go back to reference Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, Hankinson SE (2003) Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol 158:337–346CrossRefPubMed Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, Hankinson SE (2003) Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol 158:337–346CrossRefPubMed
37.
go back to reference Coleman AL, Stone KL, Kodjebacheva G, Yu F, Pedula KL, Ensrud KE, Cauley JA, Hochberg MC, Topouzis F, Badala F, Mangione CM (2008) Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol 145:1081–1089CrossRefPubMed Coleman AL, Stone KL, Kodjebacheva G, Yu F, Pedula KL, Ensrud KE, Cauley JA, Hochberg MC, Topouzis F, Badala F, Mangione CM (2008) Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol 145:1081–1089CrossRefPubMed
38.
go back to reference Lee P, Lam KW, Lai M (1977) Aqueous humor ascorbate concentration and open-angle glaucoma. Arch Ophthalmol 95:308–310PubMed Lee P, Lam KW, Lai M (1977) Aqueous humor ascorbate concentration and open-angle glaucoma. Arch Ophthalmol 95:308–310PubMed
39.
go back to reference Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Bufidis T, Georgiadis N, Ringvold A (2002) Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 134:879–883CrossRefPubMed Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Bufidis T, Georgiadis N, Ringvold A (2002) Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 134:879–883CrossRefPubMed
40.
go back to reference Elisaf M, Kitsos G, Bairaktari E, Kalaitzidis R, Kalogeropoulos C, Psilas K (2001) Metabolic abnormalities in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 79:129–132CrossRefPubMed Elisaf M, Kitsos G, Bairaktari E, Kalaitzidis R, Kalogeropoulos C, Psilas K (2001) Metabolic abnormalities in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 79:129–132CrossRefPubMed
41.
go back to reference Jampel HD, Moon JI, Quigley HA, Barron Y, Lam KW (1998) Aqueous humor uric acid and ascorbic acid concentrations and outcome of trabeculectomy. Arch Ophthalmol 116:281–285PubMed Jampel HD, Moon JI, Quigley HA, Barron Y, Lam KW (1998) Aqueous humor uric acid and ascorbic acid concentrations and outcome of trabeculectomy. Arch Ophthalmol 116:281–285PubMed
42.
go back to reference Liu KM, Swann D, Lee P, Lam KW (1984) Inhibition of oxidative degradation of hyaluronic acid by uric acid. Curr Eye Res 3:1049–1053CrossRefPubMed Liu KM, Swann D, Lee P, Lam KW (1984) Inhibition of oxidative degradation of hyaluronic acid by uric acid. Curr Eye Res 3:1049–1053CrossRefPubMed
43.
go back to reference West AL, Oren GA, Moroi SE (2006) Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol 141:157–166CrossRefPubMed West AL, Oren GA, Moroi SE (2006) Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol 141:157–166CrossRefPubMed
44.
go back to reference Rhee DJ, Katz LJ, Spaeth GL, Myers JS (2001) Complementary and alternative medicine for glaucoma. Surv Ophthalmol 46:43–55CrossRefPubMed Rhee DJ, Katz LJ, Spaeth GL, Myers JS (2001) Complementary and alternative medicine for glaucoma. Surv Ophthalmol 46:43–55CrossRefPubMed
45.
go back to reference Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E (2003) Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 110:359–362CrossRefPubMed Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E (2003) Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 110:359–362CrossRefPubMed
Metadata
Title
Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma
Authors
Kenya Yuki
Dogru Murat
Itaru Kimura
Yuichiro Ohtake
Kazuo Tsubota
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 2/2010
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1183-6

Other articles of this Issue 2/2010

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2010 Go to the issue